CLARITY trial
Full Title
CLARITY trial. A phase III, randomised, double-blind, three-arm, placebo-controlled, multi-center study to evaluate the safety and efficacy of oral cladrabine in subjects with relapsing remitting MS (RRMS)
CLARITY trial. A phase III, randomised, double-blind, three-arm, placebo-controlled, multi-center study to evaluate the safety and efficacy of oral cladrabine in subjects with relapsing remitting MS (RRMS)